AGTC Revenue and Competitors
Estimated Revenue & Valuation
- AGTC's estimated annual revenue is currently $35M per year.
- AGTC's estimated revenue per employee is $282,258
- AGTC's total funding is $185.1M.
Employee Data
- AGTC has 124 Employees.
- AGTC grew their employee count by -32% last year.
AGTC Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $15.3M | 99 | 5% | N/A | N/A |
#2 | $1.1M | 7 | -30% | N/A | N/A |
#3 | $3.7M | 24 | 4% | N/A | N/A |
#4 | $4.3M | 28 | -3% | N/A | N/A |
#5 | $2.5M | 16 | N/A | N/A | N/A |
#6 | $0.8M | 5 | 0% | N/A | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $2.5M | 16 | 7% | N/A | N/A |
#9 | $1.4M | 9 | -25% | N/A | N/A |
#10 | $0.6M | 4 | 0% | N/A | N/A |
What Is AGTC?
AGTC is based in the University's Sid Martin Biotechnology Development Incubator; this 35,000-sq. ft. facility provides start-up biotech companies with support essential for accelerating their launch into the marketplace. AGTC is one of many young biotechnology companies at the Incubator involved in the development of biotech products that will benefit our society while creating jobs to help Florida's economy.
keywords:N/A
$185.1M
Total Funding
124
Number of Employees
$35M
Revenue (est)
-32%
Employee Growth %
N/A
Valuation
N/A
Accelerator
AGTC's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, Process Development | Reveal Email/Phone |
2 | President and CEO | Reveal Email/Phone |
3 | EVP- Global Strategy and Development | Reveal Email/Phone |
4 | Exec Director In vivo Pharmacology and Toxicology | Reveal Email/Phone |
5 | Associate Director, Downstream Process Development | Reveal Email/Phone |
6 | Executive Director Quality Assurance | Reveal Email/Phone |
7 | Project Manager CQV | Reveal Email/Phone |
8 | HR Associate | Reveal Email/Phone |
9 | Director, Assay Development | Reveal Email/Phone |
10 | Senior Director, Gene Therapy & Translational Development | Reveal Email/Phone |
AGTC News
GAINESVILLE, Fla., and CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC),...
AGTC is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and...
AGTC is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and...
AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2021 -Company on track to provide multiple data readouts for XLRP and ACHM clinical programs in 2021 and 2022- -Company to host management update and webcast today at 8:00 a.m. ET- GAINESVILLE, Fla. and C ...
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare inherited retinal diseases ( ...
Other Companies in Alachua
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $34.6M | 154 | 17% | N/A |
#2 | $39M | 156 | 24% | N/A |
#3 | $83.9M | 409 | 0% | $69.9M |
#4 | $146.6M | 584 | 1% | N/A |